Clinical Trial Update: The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 study evaluated the safety and potential effects of 5% lifitegrast ophthalmic solution in subjects with dry eye disease associated with ocula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Graft-versus-host Disease

Drugs mentioned

• Lifitegrast ophthalmic solution 5% (lifitegrast)

Snippet

Sponsor: Richard W Yee, MD | Conditions: Graft-versus-host-disease, Ocular Graft-versus-host Disease | EARLY_Phase 1 | Status: COMPLETED